Malaria may not be a health concern for parents and children in the UK, but for millions of others it's a very different story. In Africa, where 90% of cases are found, families face the risk of their children getting sick or dying from the disease on a daily basis. It’s the reason scientists are working so hard to find innovative solutions and why there were so many headlines heralding official endorsement of the first malaria vaccine for this very complex disease.
Astonished and angry. Emotions not normally associated with scanning an event agenda, but those were my feelings on first reading the COP26 UK Presidency Programme. Climate change is a global health emergency and yet – once again – its impact on our species looks set to be largely ignored on the biggest stage of all. Sessions addressing the catastrophic effect of climate change on human health are few and far between. After this COVID pandemic year of all years, how is this possible?
Acute bacterial meningitis (ABM) is still a major public health challenge around the world. It affects more than five million people globally each year, and kills approximately 250,000. Those who do survive are often left with a long-lasting disability, such as hearing or visual loss, brain injury, seizures or limb amputation. ABM does not discriminate – it’s effects are seen around the world and in all age groups.
It’s more than 10 years since I first presented a statistical model to predict which countries in Africa were most at risk of a polio outbreak. Since then, our research collaboration has evolved and adapted the tool to meet current needs. With wild polio eliminated from Africa, the major concern in this region is tackling outbreaks of circulating vaccine-derived poliovirus serotype 2 (cVDPV2), which can cause permanent paralysis.
Many are still struggling in the disruptive wake of COVID-19. An open call from the World Health Organization (WHO) and the United Nations underlines the importance of social solidarity and ‘contagious’ kindness in communities response to COVID-19. Kindness and generosity, defined as the capacity to give more than is necessary or expected, that are driving people to help others are essential for us to getting through the gloomy, long-lasting fight against the pandemic.
The London School of Hygiene & Tropical Medicine (LSHTM) has a long and prestigious history of continuity and change in its mission to improve health worldwide. Changes are often in response to new challenges – as exemplified by our pivotal role in the ongoing COVID-19 pandemic, which suddenly emerged in late 2019.
It is estimated that over 3% of the world’s population required humanitarian aid in 2020. As temperatures rise and weather patterns shift, one can only imagine the number of people and financial resources needed to provide services if we continue unabated on this current dangerous path. We lack accurate figures but hypothesize that the destruction of formal structures and social safety nets during natural disasters will likely lead to increases in violence against children.
On June 10 2011, a team of us launched the World report on disability at the United Nations in New York. The first of its kind, the report reviewed the global picture on the lives of people with disabilities and provided the best available evidence on what works to enable people with disabilities to flourish. I remember well the months of writing, preparation and checking. I also remember the films we made with women with disabilities, and the launch film I made with Professor Stephen Hawking.
Mark Twain said that history does not repeat itself, but it rhymes. I’m not so sure.
Innovative science is often borne out of necessity, and this pandemic is no different. Scientists around the world have sequenced the SARS Cov-2 genome, rapidly identified COVID-19 strains and developed successful vaccines in record-breaking time to tackle the virus. COVID-19 diagnostics, such as PCR and lateral flow tests (LFT), are now an intrinsic part of our everyday lives, helping to detect cases and prevent small, localised outbreaks from becoming epidemics. However, these tools – while crucial – are invasive, costly and do not offer immediate results.